tiprankstipranks
Taki Chemical Co., Ltd. (JP:4025)
:4025
Japanese Market
Want to see JP:4025 full AI Analyst Report?

Taki Chemical Co., Ltd. (4025) AI Stock Analysis

0 Followers

Top Page

JP:4025

Taki Chemical Co., Ltd.

(4025)

Select Model
Select Model
Select Model
Outperform 77 (OpenAI - 5.2)
Rating:77Outperform
Price Target:
¥5,674.00
▲(48.34% Upside)
Action:Reiterated
Date:04/01/26
The score is driven primarily by improving profitability and a very low-debt balance sheet, supported by a low P/E valuation. Offsetting factors are inconsistent cash-flow generation and technically overbought momentum signals that raise near-term downside risk.
Positive Factors
Improving profitability
Sustained margin expansion across gross, operating and net lines indicates structural improvement in cost control, pricing or product mix. Higher margins increase resilience to input shocks, support reinvestment and raise the company's ability to generate operating earnings over the next 2–6 months and beyond.
Negative Factors
Volatile free cash flow
Large year-to-year swings in free cash flow reduce predictability of internally generated funds, complicating capital allocation. Volatility limits the firm's ability to consistently finance growth, dividends or debt reduction and raises execution risk over the coming months.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving profitability
Sustained margin expansion across gross, operating and net lines indicates structural improvement in cost control, pricing or product mix. Higher margins increase resilience to input shocks, support reinvestment and raise the company's ability to generate operating earnings over the next 2–6 months and beyond.
Read all positive factors

Taki Chemical Co., Ltd. (4025) vs. iShares MSCI Japan ETF (EWJ)

Taki Chemical Co., Ltd. Business Overview & Revenue Model

Company Description
Taki Chemical Co., Ltd. engages in the agri, chemicals, and real estate businesses in Japan. The company offers fertilizers and soil conditioners. It also provides water treatment chemicals, including polyaluminum chloride for drinking and industr...
How the Company Makes Money
null...

Taki Chemical Co., Ltd. Financial Statement Overview

Summary
Profitability improved meaningfully (gross margin ~24.4% in 2025 vs ~19.9% in 2023; net margin ~7.8% vs ~3.9%) and the balance sheet is very conservatively financed (debt-to-equity ~0.03; equity steadily rising). Offsetting this, cash-flow consistency is the main weakness with volatile free cash flow and weaker cash conversion in 2025 (FCF ~¥0.75B; ~32% of net income).
Income Statement
76
Positive
Balance Sheet
88
Very Positive
Cash Flow
58
Neutral
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue40.36B41.98B38.92B34.85B35.85B32.81B
Gross Profit9.80B10.24B8.74B6.74B8.61B8.44B
EBITDA4.49B4.53B3.91B2.06B4.03B3.85B
Net Income2.68B3.28B2.30B1.36B2.06B1.92B
Balance Sheet
Total Assets60.66B65.65B58.40B51.30B50.32B46.04B
Cash, Cash Equivalents and Short-Term Investments5.72B7.37B7.46B5.08B6.26B6.53B
Total Debt1.35B1.26B1.22B1.15B1.24B1.34B
Total Liabilities21.18B22.32B20.44B17.40B18.26B16.66B
Stockholders Equity39.05B42.89B37.88B33.82B31.95B29.24B
Cash Flow
Free Cash Flow0.00748.00M2.53B-529.00M-34.00M218.00M
Operating Cash Flow0.002.31B4.34B1.62B1.44B2.82B
Investing Cash Flow0.00-1.06B-1.61B-1.64B-1.08B-2.32B
Financing Cash Flow0.00-1.46B-352.00M-1.17B-543.00M-498.00M

Taki Chemical Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price3825.00
Price Trends
50DMA
4737.70
Positive
100DMA
4322.70
Positive
200DMA
3967.15
Positive
Market Momentum
MACD
128.95
Positive
RSI
52.16
Neutral
STOCH
21.79
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4025, the sentiment is Neutral. The current price of 3825 is below the 20-day moving average (MA) of 5088.75, below the 50-day MA of 4737.70, and below the 200-day MA of 3967.15, indicating a neutral trend. The MACD of 128.95 indicates Positive momentum. The RSI at 52.16 is Neutral, neither overbought nor oversold. The STOCH value of 21.79 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:4025.

Taki Chemical Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
¥45.18B8.513.53%-7.83%13.79%
77
Outperform
¥43.36B12.230.13%8.56%41.65%
64
Neutral
¥27.68B9.283.53%4.47%9.89%
63
Neutral
¥17.89B21.991.81%4.46%-3.54%
63
Neutral
¥28.56B15.393.45%4.08%8.34%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
43
Neutral
¥10.12B33.671.06%-7.88%129.32%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4025
Taki Chemical Co., Ltd.
5,010.00
2,126.95
73.77%
JP:4366
Daito Chemix Corporation
540.00
311.09
135.90%
JP:4463
Nicca Chemical Co., Ltd.
1,756.00
520.05
42.08%
JP:4960
Chemipro Kasei Kaisya,Ltd.
616.00
348.02
129.86%
JP:5013
Yushiro Chemical Industry Co., Ltd.
3,320.00
1,393.57
72.34%
JP:7925
Maezawa Kasei Industries Co., Ltd.
1,926.00
99.49
5.45%

Taki Chemical Co., Ltd. Corporate Events

Taki Chemical lifts Q1 profits and plans higher ordinary dividend for 2026
May 8, 2026
Taki Chemical Co., Ltd. reported that revenue for the first quarter of the fiscal year ending December 31, 2026 rose 9.2% year on year to ¥10.78 billion, with operating profit climbing 37.1% and profit attributable to owners of the parent up ...
Taki Chemical Completes Restricted Stock Compensation Share Disposal
Apr 24, 2026
Taki Chemical Co., Ltd. has completed the payment procedures for the disposal of treasury shares used as restricted stock compensation, following a March 26, 2026 board resolution. The transaction involves 9,072 shares of common stock at ¥4,8...
Taki Chemical to Grant Restricted Treasury Shares as Executive Compensation
Mar 26, 2026
Taki Chemical Co., Ltd. has approved the disposal of 9,072 treasury shares as advance-issue-type restricted stock compensation to five directors and nine executive and associate executive officers, at a price of ¥4,820 per share for a total o...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 01, 2026